Search
for
Sort by
Research 211–240 of 1000+
- Androgens and the Menopause
- Serum 1, 25-dihydroxy vitamin D- vitamin D3- among obese Egyptian women with polycystic ovary syndrome
- Serum C-19 steroid sulphates in females with clinical hyperandrogenism
- Clomiphene Citrate versus Letrozole for Ovulation Induction in PCOS: A Comparative Study
- Lack of association between clinical and biochemical hyperandrogenism in patients with polycystic ovary syndrome
- Intracrinology and Testosterone Pellet Therapy: An Enzyme-Aware, Symptom-Driven Approach to Hormone Optimization in Aging
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- (101) Ovarian Hyperthecosis as a Cause of Hypersexualization in a Post-menopausal Female
- Androgen effects on the skin
- Serum 3α-androstanediol-glucuronide is decreased in nonhirsute women with acne vulgaris
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- The diagnosis of polycystic ovary syndrome in adolescents
- The role of androgen and androgen receptor in skin-related disorders
- Structure of human type II 5 alpha-reductase gene.
- Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane
- Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor β Gene Are Associated with Androgen Levels in Women1
- Diagnosis of hyperandrogenism: Biochemical criteria
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Oestrogen functions in skin and skin appendages
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Nonclassic adrenal hyperplasia
- Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome
- A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
- Increased Androgen Binding Capacity in Sebaceous Glands in Scalp of Male-pattern Baldness
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Oxidative Activity of the Type 2 Isozyme of 17β-Hydroxysteroid Dehydrogenase (17β-HSD) Predominates in Human Sebaceous Glands
- Pharmacologic Therapy of Polycystic Ovary Syndrome
- Aromatase inhibitor therapy and hair loss among breast cancer survivors